222 related articles for article (PubMed ID: 9771840)
1. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
2. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
3. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen.
Higuchi T; Maruyama T; Jaramillo A; Mohanakumar T
J Immunol; 2005 Feb; 174(4):1871-8. PubMed ID: 15699113
[TBL] [Abstract][Full Text] [Related]
4. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
[TBL] [Abstract][Full Text] [Related]
5. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.
Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880
[TBL] [Abstract][Full Text] [Related]
6. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
8. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Hertz MI; Mueller DL
J Immunol; 2003 Dec; 171(12):6919-28. PubMed ID: 14662899
[TBL] [Abstract][Full Text] [Related]
9. Immune cells in a mouse airway model of obliterative bronchiolitis.
Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
[TBL] [Abstract][Full Text] [Related]
10. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts.
Smith MA; Jaramillo A; SivaSai KS; Naziruddin B; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Jan; 73(2):186-93. PubMed ID: 11821728
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical contributions of allorecognition pathways in chronic lung rejection.
Chalermskulrat W; Neuringer IP; Brickey WJ; Felix NJ; Randell SH; Ting JP; Aris RM
Am J Respir Crit Care Med; 2003 Apr; 167(7):999-1007. PubMed ID: 12446274
[TBL] [Abstract][Full Text] [Related]
12. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
13. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
[TBL] [Abstract][Full Text] [Related]
14. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
15. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
[TBL] [Abstract][Full Text] [Related]
16. Immune and non-immune factors in cryopreserved tissues.
Tomita Y; Yoshikawa M; Zhang Qi; Uchida T; Nakashima Y; Sueishi K; Nomoto K; Yasui H
J Heart Lung Transplant; 2003 May; 22(5):560-7. PubMed ID: 12742419
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma knockout fails to confer protection against obliteration in heterotopic murine tracheal allografts.
Batirel HF; Batirel S; Mitchell RN; Swanson SJ
J Heart Lung Transplant; 2005 Jun; 24(6):658-64. PubMed ID: 15949724
[TBL] [Abstract][Full Text] [Related]
18. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model.
Yamada A; Konishi K; Cruz GL; Takehara M; Morikawa M; Nakagawa I; Murakami M; Abe T; Todo S; Uede T
Transplantation; 2000 Mar; 69(5):743-9. PubMed ID: 10755520
[TBL] [Abstract][Full Text] [Related]
19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
20. Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference.
Ito S; Ueno M; Nishi S; Arakawa M; Ikarashi Y; Saitoh T; Fujiwara M
Autoimmunity; 1992; 12(2):79-87. PubMed ID: 1617113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
